Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform

Autor: Clara Mayo de las Casas, Mónica Garzón-Ibañez, Núria Jordana-Ariza, Santiago Viteri-Ramírez, Irene Moya-Horno, Niki Karachaliou, Zaira Yeste, Raquel Campos, Sergi Villatoro, Ariadna Balada-Bel, Beatriz García-Peláez, Noemí Reguart, Cristina Teixidó, Eloisa Jantús, Silvia Calabuig, Cristina Aguado, Ana Giménez-Capitán, Ruth Román-Lladó, Ana Pérez-Rosado, Maria José Catalán, Jordi Bertrán-Alamillo, Silvia García-Román, Sonia Rodriguez, Lidia Alonso, Erika Aldeguer, Alejandro Martínez-Bueno, Maria González-Cao, Andrés Aguilar Hernandez, Juan Garcia-Mosquera, Maria de los Llanos Gil, Manuel Fernandez, Rafael Rosell, Miguel Ángel Molina-Vila

Publikováno v: Translational Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background: In a significant percentage of advanced non-small cell lung cancer (NSCLC) patients, tumor tissue is unavailable or insufficient for genetic analyses at time to progression. We prospectively analyzed the appearance of genetic alterations

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89900d376e87821da5a898aa2ba2315e
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2879

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients

Autor: Virginie Lespinet, Virginie Tanga, Salomé Lalvée, Camille Ribeyre, Véronique Hofman, Charles-Hugo Marquette, Jérôme Mouroux, Marius Ilie, Charlotte Cohen, Paul Hofman, Sylvie Leroy, Simon Heeke, Olivier Bordone, Elodie Long-Mira, Jonathan Benzaquen

Publikováno v: Cancers, Vol 10, Iss 4, p 88 (2018)
Cancers
Cancers; Volume 10; Issue 4; Pages: 88

Background: With the integration of various targeted therapies into the clinical management of patients with advanced lung adenocarcinoma, next-generation sequencing (NGS) has become the technology of choice and has led to an increase in simultaneous

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d17a95770c62887e1a6a7f0f136f2b
https://doi.org/10.3390/cancers10040088

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.